ABPA sans asthma: an entity to remember
暂无分享,去创建一个
[1] A. Chakrabarti,et al. Evaluation of Simpler Criteria for Diagnosing Allergic Bronchopulmonary Aspergillosis Complicating Asthma , 2022, Frontiers in Cellular and Infection Microbiology.
[2] A. Shah,et al. Review of current and future therapeutics in ABPA , 2021, Therapeutic advances in chronic disease.
[3] T. Shimoda,et al. New Clinical Diagnostic Criteria for Allergic Bronchopulmonary Aspergillosis/Mycosis and its Validation. , 2020, The Journal of allergy and clinical immunology.
[4] M. Garg,et al. Allergic bronchopulmonary aspergillosis (ABPA) sans asthma: A distinct subset of ABPA with a lesser risk of exacerbation. , 2019, Medical mycology.
[5] I. Khawaja,et al. Treating Allergic Bronchopulmonary Aspergillosis: A Review , 2019, Cureus.
[6] A. Chakrabarti,et al. An Alternate Method of Classifying Allergic Bronchopulmonary Aspergillosis Based on High-Attenuation Mucus , 2010, PloS one.
[7] G. Menz,et al. [Allergic bronchopulmonary aspergillosis]. , 1996, Pneumologie.
[8] J. Glancy,et al. Allergic bronchopulmonary fungal disease without clinical asthma. , 1981, Thorax.
[9] K. Hinson,et al. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. , 1952, Thorax.